欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/0466/001
药品名称Boostrix Polio, prefilled syringe
活性成分
    • Diphtheria Toxoid 2.5 Lf
    • filamentous haemagglutinin of bordetella pertussis 8.0 µg
    • inactivated type I poliovirus 40.0 D-Antigeneinhe
    • inactivated type II poliovirus 8.0 D-Antigeneinhe
    • inactivated type III poliovirus 32.0 [no unit]
    • pertactin 2.5 µg
    • pertussis toxoid 0.0 µg
    • Tetanus Toxoid 5.0 Lf
剂型Suspension for injection
上市许可持有人GlaxoSmithKline GmbH & Co.KG Theresienhöhe 11 D-80339 München
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Spain (ES)
      BOOSTRIX POLIO SUSPENSIÓN INYECTABLE EN JERINGAS PRECARGABLES
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Boostrix Polio injektionsvätska, suspension i förfylld spruta
    • Norway (NO)
    • Finland (FI)
    • Belgium (BE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
许可日期2004/08/09
最近更新日期2016/10/13
药物ATC编码
    • J07CA02 diphtheria-pertussis-poliomyelitis-tetanus
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Biological: Vaccine
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase